▶ 調査レポート

世界の家族性アミロイドポリニューロパチー市場：市場規模・現状・予測
• 英文タイトル：Global Familial Amyloid Polyneuropathy Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の家族性アミロイドポリニューロパチー市場：市場規模・現状・予測 / Global Familial Amyloid Polyneuropathy Market Size, Status and Forecast 2019-2025 / QYR9N7193資料のイメージです。• レポートコード：QYR9N7193
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、家族性アミロイドポリニューロパチーのグローバル市場について調査・分析したレポートで、種類別（FAP-I
、FAP-II
、FAP-III
、FAP-IV
）、用途別（病院と診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・家族性アミロイドポリニューロパチーの世界市場規模
・主要企業別市場シェア
・家族性アミロイドポリニューロパチーの世界市場規模：種類別（FAP-I
、FAP-II
、FAP-III
、FAP-IV
）
・家族性アミロイドポリニューロパチーの世界市場規模：用途別（病院と診療所、その他）
・家族性アミロイドポリニューロパチーのアメリカ市場規模（種類別、用途別）
・家族性アミロイドポリニューロパチーのヨーロッパ市場規模（種類別、用途別）
・家族性アミロイドポリニューロパチーの中国市場規模（種類別、用途別）
・家族性アミロイドポリニューロパチーの日本市場規模（種類別、用途別）
・家族性アミロイドポリニューロパチーの東南アジア市場規模（種類別、用途別）
・家族性アミロイドポリニューロパチーのインド市場規模（種類別、用途別）
・家族性アミロイドポリニューロパチーの中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・家族性アミロイドポリニューロパチーの世界市場予測（2019年-2025年）
・家族性アミロイドポリニューロパチーの地域別市場予測（2019年-2025年）
...

Familial amyloid polyneuropathy (FAP) or transthyretin (TTR) amyloid neuropathy are a rare group of autosomal dominant diseases caused by the deposition of protein and/or amyloid fibrils around the peripheral nerves and in various tissues, including the heart muscle.Globally, development of new drugs for treatment of familial amyloid polyneuropathy, and rise in the prevalence of familial amyloid polyneuropathy are the prime growth drivers of familial amyloid polyneuropathy market.
In 2018, the global Familial Amyloid Polyneuropathy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Familial Amyloid Polyneuropathy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Familial Amyloid Polyneuropathy development in United States, Europe and China.

The key players covered in this study
Pfizer
GSK
Ionis
Alnylam
Corino Therapeutics
Proclara Bioscience
Arcturus Therapeutics
…

Market segment by Type, the product can be split into
FAP-I
FAP-II
FAP-III
FAP-IV

Market segment by Application, split into
Hospitals and Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Familial Amyloid Polyneuropathy status, future forecast, growth opportunity, key market and key players.
To present the Familial Amyloid Polyneuropathy development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Familial Amyloid Polyneuropathy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Familial Amyloid Polyneuropathy Market Size Growth Rate by Type (2014-2025)
1.4.2 FAP-I
1.4.3 FAP-II
1.4.4 FAP-III
1.4.5 FAP-IV
1.5 Market by Application
1.5.1 Global Familial Amyloid Polyneuropathy Market Share by Application (2014-2025)
1.5.2 Hospitals and Clinics
1.5.3 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Familial Amyloid Polyneuropathy Market Size
2.2 Familial Amyloid Polyneuropathy Growth Trends by Regions
2.2.1 Familial Amyloid Polyneuropathy Market Size by Regions (2014-2025)
2.2.2 Familial Amyloid Polyneuropathy Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Familial Amyloid Polyneuropathy Market Size by Manufacturers
3.1.1 Global Familial Amyloid Polyneuropathy Revenue by Manufacturers (2014-2019)
3.1.2 Global Familial Amyloid Polyneuropathy Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Familial Amyloid Polyneuropathy Market Concentration Ratio (CR5 and HHI)
3.2 Familial Amyloid Polyneuropathy Key Players Head office and Area Served
3.3 Key Players Familial Amyloid Polyneuropathy Product/Solution/Service
3.4 Date of Enter into Familial Amyloid Polyneuropathy Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Familial Amyloid Polyneuropathy Market Size by Type (2014-2019)
4.2 Global Familial Amyloid Polyneuropathy Market Size by Application (2014-2019)

5 United States
5.1 United States Familial Amyloid Polyneuropathy Market Size (2014-2019)
5.2 Familial Amyloid Polyneuropathy Key Players in United States
5.3 United States Familial Amyloid Polyneuropathy Market Size by Type
5.4 United States Familial Amyloid Polyneuropathy Market Size by Application

6 Europe
6.1 Europe Familial Amyloid Polyneuropathy Market Size (2014-2019)
6.2 Familial Amyloid Polyneuropathy Key Players in Europe
6.3 Europe Familial Amyloid Polyneuropathy Market Size by Type
6.4 Europe Familial Amyloid Polyneuropathy Market Size by Application

7 China
7.1 China Familial Amyloid Polyneuropathy Market Size (2014-2019)
7.2 Familial Amyloid Polyneuropathy Key Players in China
7.3 China Familial Amyloid Polyneuropathy Market Size by Type
7.4 China Familial Amyloid Polyneuropathy Market Size by Application

8 Japan
8.1 Japan Familial Amyloid Polyneuropathy Market Size (2014-2019)
8.2 Familial Amyloid Polyneuropathy Key Players in Japan
8.3 Japan Familial Amyloid Polyneuropathy Market Size by Type
8.4 Japan Familial Amyloid Polyneuropathy Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Familial Amyloid Polyneuropathy Market Size (2014-2019)
9.2 Familial Amyloid Polyneuropathy Key Players in Southeast Asia
9.3 Southeast Asia Familial Amyloid Polyneuropathy Market Size by Type
9.4 Southeast Asia Familial Amyloid Polyneuropathy Market Size by Application

10 India
10.1 India Familial Amyloid Polyneuropathy Market Size (2014-2019)
10.2 Familial Amyloid Polyneuropathy Key Players in India
10.3 India Familial Amyloid Polyneuropathy Market Size by Type
10.4 India Familial Amyloid Polyneuropathy Market Size by Application

11 Central & South America
11.1 Central & South America Familial Amyloid Polyneuropathy Market Size (2014-2019)
11.2 Familial Amyloid Polyneuropathy Key Players in Central & South America
11.3 Central & South America Familial Amyloid Polyneuropathy Market Size by Type
11.4 Central & South America Familial Amyloid Polyneuropathy Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Familial Amyloid Polyneuropathy Introduction
12.1.4 Pfizer Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 GSK
12.2.1 GSK Company Details
12.2.2 Company Description and Business Overview
12.2.3 Familial Amyloid Polyneuropathy Introduction
12.2.4 GSK Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)
12.2.5 GSK Recent Development
12.3 Ionis
12.3.1 Ionis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Familial Amyloid Polyneuropathy Introduction
12.3.4 Ionis Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)
12.3.5 Ionis Recent Development
12.4 Alnylam
12.4.1 Alnylam Company Details
12.4.2 Company Description and Business Overview
12.4.3 Familial Amyloid Polyneuropathy Introduction
12.4.4 Alnylam Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)
12.4.5 Alnylam Recent Development
12.5 Corino Therapeutics
12.5.1 Corino Therapeutics Company Details
12.5.2 Company Description and Business Overview
12.5.3 Familial Amyloid Polyneuropathy Introduction
12.5.4 Corino Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)
12.5.5 Corino Therapeutics Recent Development
12.6 Proclara Bioscience
12.6.1 Proclara Bioscience Company Details
12.6.2 Company Description and Business Overview
12.6.3 Familial Amyloid Polyneuropathy Introduction
12.6.4 Proclara Bioscience Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)
12.6.5 Proclara Bioscience Recent Development
12.7 Arcturus Therapeutics
12.7.1 Arcturus Therapeutics Company Details
12.7.2 Company Description and Business Overview
12.7.3 Familial Amyloid Polyneuropathy Introduction
12.7.4 Arcturus Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)
12.7.5 Arcturus Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Familial Amyloid Polyneuropathy Key Market Segments
Table Key Players Familial Amyloid Polyneuropathy Covered
Table Global Familial Amyloid Polyneuropathy Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Familial Amyloid Polyneuropathy Market Size Market Share by Type 2014-2025
Figure FAP-I Figures
Table Key Players of FAP-I
Figure FAP-II Figures
Table Key Players of FAP-II
Figure FAP-III Figures
Table Key Players of FAP-III
Figure FAP-IV Figures
Table Key Players of FAP-IV
Table Global Familial Amyloid Polyneuropathy Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals and Clinics Case Studies
Figure Others Case Studies
Figure Familial Amyloid Polyneuropathy Report Years Considered
Table Global Familial Amyloid Polyneuropathy Market Size 2014-2025 (Million US$)
Figure Global Familial Amyloid Polyneuropathy Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Familial Amyloid Polyneuropathy Market Size by Regions 2014-2025 (Million US$)
Table Global Familial Amyloid Polyneuropathy Market Size by Regions 2014-2019 (Million US$)
Table Global Familial Amyloid Polyneuropathy Market Share by Regions 2014-2019
Figure Global Familial Amyloid Polyneuropathy Market Share by Regions 2014-2019
Figure Global Familial Amyloid Polyneuropathy Market Share by Regions 2019
Table Market Top Trends
Table Global Familial Amyloid Polyneuropathy Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Familial Amyloid Polyneuropathy Market Share by Manufacturers (2014-2019)
Figure Global Familial Amyloid Polyneuropathy Market Share by Manufacturers in 2018
Table Global Familial Amyloid Polyneuropathy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Familial Amyloid Polyneuropathy Product/Solution/Service
Table Date of Enter into Familial Amyloid Polyneuropathy Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Familial Amyloid Polyneuropathy Market Size by Type (2014-2019) (Million US$)
Table Global Familial Amyloid Polyneuropathy Market Size Share by Type (2014-2019)
Figure Global Familial Amyloid Polyneuropathy Market Size Market Share by Type (2014-2019)
Table Global Familial Amyloid Polyneuropathy Market Size by Application (2014-2019) (Million US$)
Table Global Familial Amyloid Polyneuropathy Market Size Share by Application (2014-2019)
Figure Global Familial Amyloid Polyneuropathy Market Size Market Share by Application (2014-2019)
Figure Global Familial Amyloid Polyneuropathy Revenue Market Share by Application in 2018
Figure United States Familial Amyloid Polyneuropathy Market Size 2014-2019 (Million US$)
Table United States Key Players Familial Amyloid Polyneuropathy Revenue (2018-2019) (Million US$)
Table United States Key Players Familial Amyloid Polyneuropathy Market Share (2018-2019)
Table United States Familial Amyloid Polyneuropathy Market Size by Type (2014-2019) (Million US$)
Table United States Familial Amyloid Polyneuropathy Market Share by Type (2014-2019)
Table United States Familial Amyloid Polyneuropathy Market Size by Application (2014-2019) (Million US$)
Table United States Familial Amyloid Polyneuropathy Market Share by Application (2014-2019)
Figure Europe Familial Amyloid Polyneuropathy Market Size 2014-2019 (Million US$)
Table Europe Key Players Familial Amyloid Polyneuropathy Revenue (2018-2019) (Million US$)
Table Europe Key Players Familial Amyloid Polyneuropathy Market Share (2018-2019)
Table Europe Familial Amyloid Polyneuropathy Market Size by Type (2014-2019) (Million US$)
Table Europe Familial Amyloid Polyneuropathy Market Share by Type (2014-2019)
Table Europe Familial Amyloid Polyneuropathy Market Size by Application (2014-2019) (Million US$)
Table Europe Familial Amyloid Polyneuropathy Market Share by Application (2014-2019)
Figure China Familial Amyloid Polyneuropathy Market Size 2014-2019 (Million US$)
Table China Key Players Familial Amyloid Polyneuropathy Revenue (2018-2019) (Million US$)
Table China Key Players Familial Amyloid Polyneuropathy Market Share (2018-2019)
Table China Familial Amyloid Polyneuropathy Market Size by Type (2014-20189) (Million US$)
Table China Familial Amyloid Polyneuropathy Market Share by Type (2014-2019)
Table China Familial Amyloid Polyneuropathy Market Size by Application (2014-2019) (Million US$)
Table China Familial Amyloid Polyneuropathy Market Share by Application (2014-2019)
Figure Japan Familial Amyloid Polyneuropathy Market Size 2014-2019 (Million US$)
Table Japan Key Players Familial Amyloid Polyneuropathy Revenue (2018-2019) (Million US$)
Table Japan Key Players Familial Amyloid Polyneuropathy Market Share (2018-2019)
Table Japan Familial Amyloid Polyneuropathy Market Size by Type (2014-2019) (Million US$)
Table Japan Familial Amyloid Polyneuropathy Market Share by Type (2014-2019)
Table Japan Familial Amyloid Polyneuropathy Market Size by Application (2014-2019) (Million US$)
Table Japan Familial Amyloid Polyneuropathy Market Share by Application (2014-2019)
Figure Southeast Asia Familial Amyloid Polyneuropathy Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Familial Amyloid Polyneuropathy Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Familial Amyloid Polyneuropathy Market Share (2018-2019)
Table Southeast Asia Familial Amyloid Polyneuropathy Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Familial Amyloid Polyneuropathy Market Share by Type (2014-2019)
Table Southeast Asia Familial Amyloid Polyneuropathy Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Familial Amyloid Polyneuropathy Market Share by Application (2014-2019)
Figure India Familial Amyloid Polyneuropathy Market Size 2014-2019 (Million US$)
Table India Key Players Familial Amyloid Polyneuropathy Revenue (2018-2019) (Million US$)
Table India Key Players Familial Amyloid Polyneuropathy Market Share (2018-2019)
Table India Familial Amyloid Polyneuropathy Market Size by Type (2014-2019) (Million US$)
Table India Familial Amyloid Polyneuropathy Market Share by Type (2014-2019)
Table India Familial Amyloid Polyneuropathy Market Size by Application (2014-2019) (Million US$)
Table India Familial Amyloid Polyneuropathy Market Share by Application (2014-2019)
Figure Central & South America Familial Amyloid Polyneuropathy Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Familial Amyloid Polyneuropathy Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Familial Amyloid Polyneuropathy Market Share (2018-2019)
Table Central & South America Familial Amyloid Polyneuropathy Market Size by Type (2014-2019) (Million US$)
Table Central & South America Familial Amyloid Polyneuropathy Market Share by Type (2014-2019)
Table Central & South America Familial Amyloid Polyneuropathy Market Size by Application (2014-2019) (Million US$)
Table Central & South America Familial Amyloid Polyneuropathy Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Familial Amyloid Polyneuropathy Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2014-2019)
Table Pfizer Recent Development
Table GSK Company Details
Table GSK Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2014-2019)
Table GSK Recent Development
Table Ionis Company Details
Table Ionis Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)(Million US$)
Figure Ionis Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2014-2019)
Table Ionis Recent Development
Table Alnylam Company Details
Table Alnylam Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)(Million US$)
Figure Alnylam Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2014-2019)
Table Alnylam Recent Development
Table Corino Therapeutics Company Details
Table Corino Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)(Million US$)
Figure Corino Therapeutics Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2014-2019)
Table Corino Therapeutics Recent Development
Table Proclara Bioscience Company Details
Table Proclara Bioscience Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)(Million US$)
Figure Proclara Bioscience Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2014-2019)
Table Proclara Bioscience Recent Development
Table Arcturus Therapeutics Company Details
Table Arcturus Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2014-2019)(Million US$)
Figure Arcturus Therapeutics Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2014-2019)
Table Arcturus Therapeutics Recent Development
Table Global Familial Amyloid Polyneuropathy Market Size by Regions (Million US$) 2019-2025
Figure Global Familial Amyloid Polyneuropathy Market Size Share by Regions (2019-2025)
Figure Global Familial Amyloid Polyneuropathy Market Size Share by Regions in 2025
Figure United States Familial Amyloid Polyneuropathy Market Size Forecast (2019-2025)(Million USD)
Figure Europe Familial Amyloid Polyneuropathy Market Size Forecast (2019-2025)(Million USD)
Figure China Familial Amyloid Polyneuropathy Market Size Forecast (2019-2025)(Million USD)
Figure Japan Familial Amyloid Polyneuropathy Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Familial Amyloid Polyneuropathy Market Size Forecast (2019-2025)(Million USD)
Figure India Familial Amyloid Polyneuropathy Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Familial Amyloid Polyneuropathy Market Size Forecast (2019-2025)(Million USD)
Table Global Familial Amyloid Polyneuropathy Market Size by Product (2019-2025) (Million US$)
Figure Global Familial Amyloid Polyneuropathy Market Size by Product (2019-2025)
Figure Global Familial Amyloid Polyneuropathy Market Size by Product in 2025
Table Global Familial Amyloid Polyneuropathy Market Size by Application (2019-2025) (Million US$)
Figure Global Familial Amyloid Polyneuropathy Market Size by Application (2019-2025)
Figure Global Familial Amyloid Polyneuropathy Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界の家族性腺腫性ポリポーシス治療市場2019
    Global Familial Adenomatous Polyposis Treatment Sales Market Report 2019
    QYR9N0916 2019年6月10日 100Pages
    本調査レポートでは、家族性腺腫性ポリポーシス治療の世界市場について調査・分析し、家族性腺腫性ポリポーシス治療のメーカー別販売量、市場シェア分析、種類別販売分析（イコサペント、塩酸エルフロニチン、アスピリン、CEQ-508、その他）、用途別販売分析（診療所、病院、その他）、地域別販売分析（米国、ヨーロ...
  • 世界のホモ接合型家族性高コレステロール血症の治療市場2019
    Global Homozygous Familial Hypercholesterolemia Treatment Sales Market Report 2019
    QYR9N1684 2019年6月10日 107Pages
    本調査レポートでは、ホモ接合型家族性高コレステロール血症の治療の世界市場について調査・分析し、ホモ接合型家族性高コレステロール血症の治療のメーカー別販売量、市場シェア分析、種類別販売分析（AEM-2802、AEM-2814、アリロクマブ、エビナクマブ、その他）、用途別販売分析（診療所、病院、その他）...
  • 世界の周期性発熱症候群市場：市場規模・現状・予測
    Global Periodic Fever Syndrome Market Size, Status and Forecast 2019-2025
    QYR9N7792 2019年6月14日 96Pages
    当資料は、周期性発熱症候群のグローバル市場について調査・分析したレポートで、種類別（高免疫グロブリン血症D症候群、家族性地中海熱、TNF受容体関連周期性症候群、クリオピリン関連周期症候群、その他）、用途別（病院、小売薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の...
  • 世界の光原子時計市場：市場規模・現状・予測
    Global Optical Atomic Clocks Market Size, Status and Forecast 2019-2025
    QYR9N7711 2019年6月14日 92Pages
    当資料は、光原子時計のグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（地上アプリケーション、宇宙アプリケーション）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
    ...
  • 世界の5Gワイヤレステクノロジ市場：市場規模・現状・予測
    Global 5G Wireless Technology Market Size, Status and Forecast 2019-2025
    QYR9N8229 2019年6月14日 97Pages
    当資料は、5Gワイヤレステクノロジのグローバル市場について調査・分析したレポートで、種類別（タイプI、タイプII）、用途別（自動車、携帯電話、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
  • 世界のロミプロスチム市場：市場規模・現状・予測
    Global Romiplostim Market Size, Status and Forecast 2019-2025
    QYR9N7982 2019年6月14日 92Pages
    当資料は、ロミプロスチムのグローバル市場について調査・分析したレポートで、種類別（250 μg/0.5 mL
    、500 μg/1 mL
    ）、用途別（大人、小児患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...
  • 世界のラパチニブ市場：市場規模・現状・予測
    Global Lapatinib Market Size, Status and Forecast 2019-2025
    QYR9N7436 2019年6月14日 98Pages
    当資料は、ラパチニブのグローバル市場について調査・分析したレポートで、種類別（250 mg錠、タイプII）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

    ・...
  • 世界のA2Pメッセージング市場：市場規模・現状・予測
    Global A2P Messaging Market Size, Status and Forecast 2019-2025
    QYR9N8232 2019年6月14日 92Pages
    当資料は、A2Pメッセージングのグローバル市場について調査・分析したレポートで、種類別（グレイルートA2P SMS、OTT A2Pメッセージング、その他）、用途別（銀行業、発券業務、健康管理、コンテンツ支払い、オペレータの関与、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、イン...
  • 世界のプレリキサフォル市場：市場規模・現状・予測
    Global Plerixafor Market Size, Status and Forecast 2019-2025
    QYR9N7839 2019年6月14日 93Pages
    当資料は、プレリキサフォルのグローバル市場について調査・分析したレポートで、種類別（24MG / 1.2ML、タイプII）、用途別（非ホジキンリンパ腫（NHL）患者、多発性骨髄腫（MM）患者）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...
  • 世界の量子コンピュータ市場：市場規模・現状・予測
    Global Quantum Computers Market Size, Status and Forecast 2019-2025
    QYR9N7916 2019年6月14日 99Pages
    当資料は、量子コンピュータのグローバル市場について調査・分析したレポートで、種類別（ゲートレベル、量子アニーリング）、用途別（計算化学、機械学習、財務の最適化、物流とスケジューリング、ドラッグデザイン、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市...
  • 世界の家族性腺腫性ポリポーシス治療市場2019世界の家族性腺腫性ポリポーシス治療市場2019 The global Familial Adenomatous Polyposis Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Familial Adenomatous Polyposis Treatment market status and forecast, categorizes the globa…
  • 世界のホモ接合型家族性高コレステロール血症の治療市場2019世界のホモ接合型家族性高コレステロール血症の治療市場2019 The global Homozygous Familial Hypercholesterolemia Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Homozygous Familial Hypercholesterolemia Treatment market status and forecast, c…
  • 世界の周期性発熱症候群市場：市場規模・現状・予測世界の周期性発熱症候群市場：市場規模・現状・予測 Periodic fever syndrome are a set of disorders characterized by recurrent episodes of systemic and organ-specific inflammation.The syndromes are diverse, but tend to cause episodes of fever, joint pains, skin rashes, abdominal pains and may lead to chronic complications such as amyloidosis. In 2018,…
  • 世界の病院市場：市場規模・現状・予測世界の病院市場：市場規模・現状・予測 A hospital is a health care institution providing patient treatment with specialized medical and nursing staff and medical equipment.In 2018, the global Hospitals market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This r…
  • 世界のマイクロ病院市場：市場規模・現状・予測世界のマイクロ病院市場：市場規模・現状・予測 Micro-hospitals are small-scale inpatient facilities on two to three-story buildings built on 20,000 to 50,000-square foot spaces that offer a wide range of medical services in a small, neighborhood setting. They run 24/7, all year long, and commonly have between eight and 10 beds where patients can…